Clinical trial
POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With…
NCT00234676 · The Parkinson Study Group, Other · Completed
Key facts
| NCT number | NCT00234676 |
|---|---|
| Title | POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease |
| Official title | A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study for the Safety, Tolerability and Efficacy of Estrogen Replacement Therapy (Conjugated Equine Estrogens 0.625 mg Daily) in Post Menopausal Women With Parkinson's Disease |
| Lead sponsor | The Parkinson Study Group, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry Joseph and Rosalyn Newman Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Premarin ® |
| Enrollment | 23 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Oct 7, 2005 |
| Last update posted | Jan 8, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: